It acts as a tumor suppressor by binding directly to p53, increasing levels of Fe2+ and ROS, and inhibiting GSH expression, which induces ferroptosis in pancreatic cancer cells [59]. This evidence concerns the gene TP53 and familial pancreatic carcinoma.